Last10K.com

Predictive Oncology Inc. (POAI) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023

Predictive Oncology Inc.

CIK: 1446159 Ticker: POAI
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 18, 2024
Jun. 30, 2023
Document Information [Line Items]   
Document Type10-K  
Document Annual Reporttrue  
Document Period End DateDec. 31, 2023  
Document Transition Reportfalse  
Entity File Number001-36790  
Entity Registrant NamePredictive Oncology Inc.  
Entity Incorporation, State or Country CodeDE  
Entity Tax Identification Number33-1007393  
Entity Address, Address Line One91 43rd Street, Suite 110  
Entity Address, City or TownPittsburgh  
Entity Address, State or ProvincePA  
Entity Address, Postal Zip Code15201  
City Area Code412  
Local Phone Number432-1500  
Title of 12(b) SecurityCommon stock, $0.01 par value  
Trading SymbolPOAI  
Security Exchange NameNASDAQ  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
ICFR Auditor Attestation Flagfalse  
Document Financial Statement Error Correction [Flag]false  
Entity Shell Companyfalse  
Entity Public Float  $ 18,983,374
Entity Common Stock, Shares Outstanding (in shares) 4,062,853 
Auditor NameBDO USA, P.C.  
Auditor LocationMinneapolis, Minnesota  
Auditor Firm ID243  
Entity Central Index Key0001446159  
Current Fiscal Year End Date--12-31  
Document Fiscal Year Focus2023  
Document Fiscal Period FocusFY  
Amendment Flagfalse  

View differences made from one year to another to evaluate Predictive Oncology Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Predictive Oncology Inc..

Continue

Assess how Predictive Oncology Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Predictive Oncology Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Net Loss
Consolidated Statements Of Stockholders' Equity
Insider Trading Arrangements
Note 1 - Summary Of Significant Accounting Policies
Note 1 - Summary Of Significant Accounting Policies (Details Textual)
Note 1 - Summary Of Significant Accounting Policies (Tables)
Note 1 - Summary Of Significant Accounting Policies - Property, Plant And Equipment Useful Life (Details)
Note 10 - Income Taxes
Note 10 - Income Taxes (Details Textual)
Note 10 - Income Taxes (Tables)
Note 10 - Income Taxes - Components Of Deferred Income Taxes (Details)
Note 10 - Income Taxes - Reconciliation Of Income Tax Benefit (Expense) (Details)
Note 11 - Collaborative Agreement
Note 12 - Retirement Savings Plans
Note 12 - Retirement Savings Plans (Details Textual)
Note 13 - Loss Per Share
Note 13 - Loss Per Share (Tables)
Note 13 - Loss Per Share - Antidilutive Securities Excluded From The Diluted Calculations (Details)
Note 13 - Loss Per Share - Shares Used In Basic And Diluted Loss Per Common Share Computations (Details)
Note 14 - Segments
Note 14 - Segments (Details Textual)
Note 14 - Segments (Tables)
Note 14 - Segments - Segments (Details)
Note 15 - Subsequent Events
Note 15 - Subsequent Events (Details Textual)
Note 2 - Fair Value Measurements
Note 2 - Fair Value Measurements (Tables)
Note 2 - Fair Value Measurements - Fair Value, Assets Measured On Recurring Basis (Details)
Note 3 - Inventories
Note 3 - Inventories (Tables)
Note 3 - Inventories - Schedule Of Inventory (Details)
Note 4 - Property And Equipment
Note 4 - Property And Equipment (Details Textual)
Note 4 - Property And Equipment (Tables)
Note 4 - Property And Equipment - Schedule Of Property, Plant And Equipment (Details)
Note 5 - Intangible Assets
Note 5 - Intangible Assets (Details Textual)
Note 5 - Intangible Assets (Tables)
Note 5 - Intangible Assets - Components Of Intangible Assets (Details)
Note 5 - Intangible Assets - Estimated Future Amortization Expense (Details)
Note 5 - Intangible Assets - Goodwill (Details)
Note 6 - Leases
Note 6 - Leases (Details Textual)
Note 6 - Leases (Tables)
Note 6 - Leases - Lease Information (Details)
Note 6 - Leases - Rent Obligation (Details)
Note 7 - Notes Payable
Note 7 - Notes Payable (Details Textual)
Note 8 - Derivatives
Note 8 - Derivatives (Details Textual)
Note 8 - Derivatives (Tables)
Note 8 - Derivatives - Change In Fair Value Of Derivative Liabilities (Details)
Note 9 - Stockholders' Equity, Stock Options And Warrants
Note 9 - Stockholders' Equity, Stock Options And Warrants (Details Textual)
Note 9 - Stockholders' Equity, Stock Options And Warrants (Tables)
Note 9 - Stockholders' Equity, Stock Options And Warrants - Schedule Of Listing Of Stock Options And Warrants (Details)
Note 9 - Stockholders' Equity, Stock Options And Warrants - Stock Offerings (Details)
Note 9 - Stockholders' Equity, Stock Options And Warrants - Summary Of Status Of Options And Warrants Outstanding (Details)
Note 9 - Stockholders' Equity, Stock Options And Warrants - Summary Of Transactions For Stock Options And Warrants (Details)
Significant Accounting Policies (Policies)
Ticker: POAI
CIK: 1446159
Form Type: 10-K Annual Report
Accession Number: 0001171843-24-001694
Submitted to the SEC: Thu Mar 28 2024 5:28:42 PM EST
Accepted by the SEC: Thu Mar 28 2024
Period: Sunday, December 31, 2023
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/poai/0001171843-24-001694.htm